“Results of a Phase 2 Multicenter Study Evaluating the Safety and Tolerability of VP-315, an Investigational Therapy for Basal Cell Carcinoma”, J of Skin, vol. 8, no. 6, p. s480, Nov. 2024, doi: 10.25251/skin.8.supp.480.